Robert M Paris

Summary

Affiliation: Armed Forces Research Institute of Medical Sciences
Country: Thailand

Publications

  1. doi Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
    Robert M Paris
    US Military HIV Research Program MHRP, Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, 315 6 Rajvithi Road, Bangkok, 10400, Thailand
    Expert Rev Vaccines 9:1055-69. 2010
  2. ncbi HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting
    R Paris
    Department of Retrovirology, U S Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Tissue Antigens 64:251-6. 2004
  3. ncbi A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
    Prasert Thongcharoen
    Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
    J Acquir Immune Defic Syndr 46:48-55. 2007
  4. pmc The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope
    Mark S de Souza
    U S Military HIV Research Program U S Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok 10400, Thailand
    J Immunol 188:5166-76. 2012
  5. doi Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E
    Supachai Rerks-Ngarm
    Department of Disease Control, Ministry of Public Health, Bangkok, Thailand
    J Infect Dis 207:1195-205. 2013
  6. ncbi Changes in HIV prevalence among young Thai men as defined by hepatitis C co-infection as a marker for mode of transmission
    Penprapa Chanbancherd
    Army Institute of Pathology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS 18:2339-41. 2004
  7. doi Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors
    Wiriya Rutvisuttinunt
    Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS Res Hum Retroviruses 28:1703-11. 2012
  8. ncbi Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand
    Chitraporn Karnasuta
    Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Vaccine 23:2522-9. 2005
  9. pmc IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
    Nicos Karasavvas
    1 Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS Res Hum Retroviruses 31:1178-86. 2015
  10. ncbi Use of dried blood spots for HIV-1 genotyping in Southeast Asia: Thailand experience
    Wiriya Rutvisuttinunt
    Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 43:333-9. 2012

Collaborators

Detail Information

Publications12

  1. doi Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
    Robert M Paris
    US Military HIV Research Program MHRP, Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, 315 6 Rajvithi Road, Bangkok, 10400, Thailand
    Expert Rev Vaccines 9:1055-69. 2010
    ....
  2. ncbi HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting
    R Paris
    Department of Retrovirology, U S Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Tissue Antigens 64:251-6. 2004
    ..These results strengthen the importance of assessing HLA class I distributions in conjunction with studies of vaccines designed to elicit cellular immunity in different populations...
  3. ncbi A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost
    Prasert Thongcharoen
    Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
    J Acquir Immune Defic Syndr 46:48-55. 2007
    ..A prime-boost HIV-1 vaccine trial assessing safety and immunogenicity was conducted in Thailand as part of an evaluation of candidate regimens for a phase 3 efficacy trial...
  4. pmc The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope
    Mark S de Souza
    U S Military HIV Research Program U S Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok 10400, Thailand
    J Immunol 188:5166-76. 2012
    ..Although the RV144 T cell responses were modest in frequency compared with humoral immune responses, the CD4(+) T cell response was directed to HIV-1 Env and more particularly the V2 region...
  5. doi Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E
    Supachai Rerks-Ngarm
    Department of Disease Control, Ministry of Public Health, Bangkok, Thailand
    J Infect Dis 207:1195-205. 2013
    ..Here we evaluated the effect of vaccination on disease progression after infection...
  6. ncbi Changes in HIV prevalence among young Thai men as defined by hepatitis C co-infection as a marker for mode of transmission
    Penprapa Chanbancherd
    Army Institute of Pathology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS 18:2339-41. 2004
    ..93-0.46%). This suggests that HIV-1 infection associated with parenteral transmission has been stable despite a dramatic reduction in the sexual transmission of HIV-1...
  7. doi Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donors
    Wiriya Rutvisuttinunt
    Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS Res Hum Retroviruses 28:1703-11. 2012
    ..This study found two unique CRF01B recombinants circulating in 10 recent HIV-1-positive subjects from a blood donor population in Thailand...
  8. ncbi Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand
    Chitraporn Karnasuta
    Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Vaccine 23:2522-9. 2005
    ..The results demonstrate that this HIV vaccine is a potent inducer of ADCC activity and may be an additional protection of this prime-boost vaccine in preventing HIV disease...
  9. pmc IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
    Nicos Karasavvas
    1 Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    AIDS Res Hum Retroviruses 31:1178-86. 2015
    ..However, notable differences in the structure of the recombinant proteins and dosage used for immunizations may have contributed to the magnitude and specificity of IgG induced by the two trials. ..
  10. ncbi Use of dried blood spots for HIV-1 genotyping in Southeast Asia: Thailand experience
    Wiriya Rutvisuttinunt
    Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 43:333-9. 2012
    ..CRF01_AE was the predominant subtype identified using plasma samples (51/62) and DBS (24/27). There was no discordance in subtype designations between plasma and DBS...
  11. ncbi Functional variation of HIV-1 Rev Response Element in a longitudinally studied cohort
    Angsana Phuphuakrat
    Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
    J Med Virol 75:367-73. 2005
    ..These data suggest that RRE heterogeneity may be important in viral pathogenesis and disease progression...
  12. ncbi High frequency of HIV-1 and hepatitis C co-infection among young Thai men: evidence for a changing pattern of HIV transmission in Thailand
    Penprapa Chanbancherd
    Army Institute of Pathology, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 34:580-2. 2003
    ..Antibody to HCV was present in 49.5% of HIV-infected men and 2.2% among uninfected men. These data suggest that a significant number of HIV infections among young men in Thailand may be associated with injection drug use...